NCT04828772View on ClinicalTrials.gov

A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

CompletedOBSERVATIONAL
Enrollment

9,282

Participants

Timeline

Start Date

August 17, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

February 7, 2022

Conditions
COVID-19
Trial Locations (2)

108-0074

Local Institution, Minato-ku

Unknown

Medical Data Vision, Tokyo

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY